Alector, Inc. Banner Image

Alector, Inc. has reached its limit for free report views

Work for Alector, Inc.? Upgrade Your Profile and unlock all your annual reports.

Alector, Inc.

  • Ticker ALEC
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Alector, Inc. Logo Image
  • 51-200 Employees
  • Based in South San Francisco, California
Alector is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Immuno-neurology targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. Alector is developing a broad portfolio of programs designed to functionally repair genetic mutationsMore that cause dysfunction of the brain’s immune system and enable the rejuvenated immune cells to counteract emerging brain pathologies. The Company’s product candidates are supported by biomarkers and target genetically defined patient populations in frontotemporal dementia and Alzheimer’s disease. Alector is headquartered in South San Francisco, California.
4.8 / 5.0 (102)

Alector, Inc. reports have an aggregate usefulness score of 4.8 based on 102 reviews.

Alector, Inc.

Most Recent Annual Report

Alector, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Report Locked. Alector, Inc. has reached its limit for free report views.

Older/Archived Annual Reports

Alector, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!